Healthy Brain Ageing (HeBA)
We are building a scientific data platform for the research on risk prediction of neurodegenerative disorders in ageing European population.
Scientific Data
A robust scientific data infrastructure for neurodegenerative diseases is crucial for advancing research and improving patient outcomes. This infrastructure enables efficient collection, storage, and sharing of diverse data sets, including genetic, clinical, and imaging data. It promotes collaboration, accelerates discoveries, and facilitates personalized treatment strategies. With enhanced data infrastructure, researchers can unravel disease mechanisms, identify biomarkers, and develop effective therapies, ultimately leading to better management of neurodegenerative diseases.
- Projects:
- HeBA Study
HeBA Study
The HeBA study aims to predict Parkinson's disease risk and identify at-risk individuals among Europeans aged 50-80 who are not diagnosed with Parkinson's or dementia. Participants will complete an in-depth online questionnaire covering demographics, occupation, lifestyle, and medical history. The collected information will be used to calculate risk scores and offer high-risk individuals the opportunity for further clinical assessments.
HeBA Study is supported by 
Michael J Fox Foundation
HeBA Study sites
Austria: 
Universitätsklinik für Neurologie Innsbruck - gesundaltern.at
Germany: 
Paracelsus-Elena-Klinik Kassel - gesundaltern.eu
Luxembourg: 
National Centre of Excellence in Research on Parkinson’s Disease heba.lu
Spain: 
Unitat de Parkinson de l'Hospital Clínic de Barcelona cervellsaludable.cat
